Bausch Health Companies Inc. buy tamam
Start price
14.12.18
/
50%
€21.56
Target price
17.12.18
€29.80
Performance (%)
-12.11%
End price
17.12.18
€18.95
Summary
This prediction ended on 17.12.18 with a price of €18.95. The price of Bausch Health Companies Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.11%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | -0.957% | -0.957% | -18.398% | -18.814% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by tamam for this prediction
In the thread Bausch Health Companies Inc. diskutieren
Bausch Health Companies Acquires 2 Possible Blockbuster Drugs for $200 Million from SGYP
tamam stimmt am 14.12.2018 der Buy-Einschätzung von Subdi mit dem Kursziel 29,8$ zu.
Überschrift: Name change to Bausch Health Companies Inc.
(Stop Loss Kurs erreicht)
Stopped prediction by tamam for Bausch Health Companies Inc.
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€18.10
18.12.18
18.12.18
€29.80
19.12.18
19.12.18
0.00%
19.12.18
19.12.18
